|
Institute for
Neuromusculoskeletal
Research, OU-COM
awarded grant for
research on rare
balance disorder
(Athens,
Ohio)
Brian
C.
Clark,
Ph.D.,
assistant
professor
of
physiology
in
the
Department
of
Biomedical
Sciences
and
the
director
of
the
Institute
for
Neuromusculoskeletal
Research
at
the
Ohio
University
College
of
Osteopathic
Medicine,
has
received
a
$20,000
grant
from
the
Mal
de
Debarquement
Syndrome
(MdDS)
Balance
Disorder
Foundation
(www.mddsfoundation.org)
to
conduct
a
research
study
on
MdDS,
a
rare
balance
disorder.
Mal de Debarquement
(French for
“disembarkation
sickness”) is a
false but persistent
sensation of motion,
such as rocking,
swaying, tumbling or
bobbing that usually
develops after a
cruise, aircraft
flight, train or car
travel. The most
common symptoms of
MdDS include
dizziness,
unsteadiness,
fatigue, confusion,
visual disturbances,
difficulty
concentrating and
anxiety. Being in an
enclosed space or
attempting to be
motionless, such as
sitting, lying down
or standing in a
stationary position,
often increases
symptoms. Symptoms
tend to decrease
when the person is
in a moving car,
airplane or train.
According to Dr.
Clark, there is no
definitive
diagnostic test for
MdDS. “It’s a
diagnosis of
exclusion, meaning
it’s only diagnosed
after all the basic
tests, such as blood
work, MRI and inner
ear exams are
conducted and
nothing is found,”
he explained.
As such, he noted,
MdDS may be
under-diagnosed.
“There are currently
no treatment options
for MdDS, and the
condition can range
from mild to totally
disabling,”
Dr. Clark and his
collaborator Adam
Quick, M.D.
(Department of
Neurology at The
Ohio State
University) recently
published their case
study findings on a
patient with MdDS in
the Journal of
Neurology, and the
upcoming study,
titled “Role of
Intracortical
Excitability in Mal
de Debarquement
Syndrome,” will
expand on these
preliminary findings
by measuring brain
excitability in MdDS
patients using
sophisticated
neurophysiologic
techniques,
including
transcranial
magnetic stimulation
(TMS).
According to Dr.
Clark, TMS is a safe
and non-invasive
technique. “It’s a
simple, painless
procedure, and the
person is totally
alert the entire
time,” he explained.
“First, we place
electrodes on the
muscles of the
person’s forearm. We
then introduce a
very brief, rapidly
changing magnetic
field over their
head. This causes
brain neurons to
fire and transmit
signals to motor
neurons. The result
is a slight
contraction in the
person’s forearm
muscles.”
A combination of
single and double
pulses is
administered to the
subject’s brain at
different intervals
and under different
conditions, such as
having the
individual open or
close their eyes and
having them rest or
contract their
forearm muscles.
Based on the
magnitude of the
electrical signals,
researchers can
assess the
excitability of a
subject’s motor
cortex. The brain’s
motor cortex deals
with the planning,
controlling, and
execution of
voluntary motor
functions, such as
lifting an object or
climbing a flight of
stairs. “This
will help us
understand the
neuronal connections
in the brain as well
as its plasticity,
which refers to the
brain’s ability to
change as a result
of one's
experience,” Dr.
Clark explained.
“The information is
important because it
will help us
identify what’s
different about the
nervous system of
people with MdDS.”
Dr. Clark will also
work closely with
Thad Wilson, Ph.D.
in the Department of
Biomedical Sciences
at Ohio University
to also look at the
ability of the
autonomic nervous
system – which
controls and
modulates many
involuntary
reflexes, such as
heart rate and blood
pressure – to adjust
to certain
environmental
conditions.
“We’ll measure the
beat–to-beat
variability in heart
rate and blood
pressure and examine
how this changes in
response to certain
tasks, such as
moving someone’s
head in a certain
direction or having
them go from lying
down to an upright
posture very
rapidly,” he
explained.
The study will
enlist 24
participants who’ll
receive $150 each.
Half of the
participants must
have been diagnosed
with MdDS and the
other 12 must be
free of the disease
but be the same
gender and age as
those with the
disorder. It is
expected that the
majority of patients
with MdDS will be
travelling to Ohio
University from all
over the United
States to
participate in the
study.
Research is expected
to begin in early
January, with all
data collected
within six months,
and the study
completed within a
year.
According to Dr.
Clark, the research
is clinically
significant because
it will be one of
the first
experiments to
explore the
pathophysiology, or
changes in normal
brain function,
associated with MdDS.
“Our findings will
provide a better
understanding of
this devastating and
poorly understood
balance disorder,”
he notes.
“Hopefully, it can
lead to developing
techniques and
criteria for
diagnosis as well as
treatment
strategies.”
If you are
interested in
participating in
this study, either
as a patient with
MdDS or as a control
subject, contact
Clark at
clarkb2@ohio.edu
for more
information.
|